GrandeLASH-MD, GrandeBROW, and GrandeHAIR Serums
Allegations: Deceptively marketing products as safe cosmetics with no active drug ingredient and no serious side effects when the active ingredient in them is found in prescription drugs that grow…
Grande Enhancement Serums
Case Name (Date)
Nixon et al. v. Grande Cosmetics, LLC
22-cv-6639, D.N.J.
(Nov. 2022)
Product/Service
Grande cosmetics, including GrandeLASH-MD Lash Enhancing Serum, GrandeBROW Brow Enhancing Serum, and GrandeHAIR Enhancement Serum
Allegations
Failing to disclose that products contain an active ingredient found in prescription drugs (isopropyl cloprostenate), which may cause serious side effects and which the FDA has only approved for use under the supervision of a doctor
Status
Settled
(Final approval granted)
Class-Action Tracker
Grande Enhancement Serums
Allegations: Misleadingly marketing products as safe cosmetics when they are actually drugs that contain an ingredient that poses serious health risks
The Latest
Decoding Cosmetics Claims: Eyelash Serums
Common ingredient raises potential health risks not always clearly disclosed in the marketing.